Search Results
Sep 12, 2026, 05:15 ET SystImmune, Inc. to Present New Global Data on Iza-bren (izalontamab brengitecan) in EGFR-mutated Non-Small Cell Lung Cancer at WCLC Congress 2026
randomized dose-expansion results demonstrate promising clinical activity, with higher efficacy observed at the 2.5 mg/kg dose level with a manageable safety profile, and support 2.5 mg/kg D1D8 Q3W as the recommended Phase 3 dose for IZABRIGHT-Lung01, the global registrational study of iza-bren in EGFR-mutated
More news about: SystImmune, Inc.
Sep 11, 2026, 11:36 ET /C O R R E C T I O N -- Octapharma/
deficiency has been associated with thrombosis at target plasma fibrinogen levels that were below 150 mg/dL. The thrombotic risks may be greater when the target fibrinogen plasma level is 150 mg/dL. Weigh the benefits of administration versus the risks of thrombosis.fibryga® is made
More news about: Octapharma
Sep 10, 2026, 19:20 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
cancer (LG IR NMIBC)." While the Company said that the data indicated a favorable safety profile, 14% and 9% of participants in the 60 mg once-daily ("QD") and 50 mg QD dose cohorts experienced Grade 3 treatment-emergent adverse events. On this news, Tyra's stock price fell $4.72 per share, or
More news about: Pomerantz LLP
Sep 10, 2026, 18:48 ET Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
higher dose formulation versus standard dose influenza vaccinesEach dose contains 45 micrograms of haemagglutinin per influenza strain and 19.5 mg of MF59 adjuvant2About CSL SeqirusCSL Seqirus is part of CSL (ASX: CSL). As one of the largest influenza vaccine
More news about: CSL Seqirus
Sep 10, 2026, 18:40 ET Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
higher dose formulation versus standard dose influenza vaccinesEach dose contains 45 micrograms of haemagglutinin per influenza strain and 19.5 mg of MF59 adjuvant2About CSL SeqirusCSL Seqirus is part of CSL (ASX: CSL). As one of the largest influenza vaccine
More news about: CSL Seqirus
Sep 10, 2026, 13:03 ET Bucked Up® Drops Six Limi-Dead Edition Halloween Pre-Workout Flavors and a Caramel Apple Energy Drink
can, so the whole roster shares one flavor no matter which product someone runs.A Stim for Every Tolerance The drop spans 200mg to 400mg of caffeine per serving,* so there's a version for every tolerance. LFG Burn® promotes calories burned during exercise.* Every formula keeps the
More news about: Bucked Up
Sep 10, 2026, 12:00 ET 2O3 Launches a Performance Hydration Beverage With Electrolytes and Honey
consumer-products entrepreneur Nelson Cury, today announced that its first ready-to-drink beverage is now available. The beverage combines 1,000 mg of sodium, 340 mg of potassium, and 60 mg of magnesium with honey to support faster hydration and provide both readily available and sustained energy.
More news about: 2O3
Sep 10, 2026, 10:31 ET Obesity Market Set for Explosive 27% CAGR Growth by 2036, Fueled by 7 Promising Emerging Therapies | DelveInsight
CagriSema in the second half of 2026, combining cagrilintide 2.4 mg with Wegovy HD (injectable semaglutide 7.2 mg). Meanwhile, the Phase III REDEFINE 11 study is assessing the full weight-loss potential of the existing 2.4 mg/2.4 mg combination in adults with obesity, with results anticipated in
More news about: DelveInsight Business Research, LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
treatment of wet age-related macular degeneration (wet AMD)." The press release disclosed that change from baseline in best corrected visual acuity versus 2 mg aflibercept (Regeneron Pharmaceuticals' (REGN) Eylea) was not met in the entire dataset. On this news, EyePoint's stock price fell $9.88 per share,
More news about: Pomerantz LLP
Sep 10, 2026, 08:55 ET AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine
QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA.QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
More news about: AbbVie
Sep 10, 2026, 08:00 ET Roland DG Launches the TrueVis MG2 Series, Helping Print Businesses Unlock Higher-Value UV Applications with Greater Productivity and Profitability
manufacturer of wide-format digital printing solutions, today announced the launch of the TrueVis MG2 Series, a next-generation UV printer/cutter range comprised of the 64-inch MG2-640 and 30-inch MG2-300. Designed to help print businesses increase profitability, the new series combines significantly higher
More news about: Roland DGA
Sep 10, 2026, 08:00 ET Chega ao Brasil novo anticorpo monoclonal para prevenir o VSR em recém-nascidos e bebês
de clesrovimabe para reduzir a carga da doença sobre famílias e sistemas de saúde.Clesrovimabe é disponibilizado em apresentação única de 105 mg, independente do peso corporal. Essa característica pode contribuir para simplificar os processos de administração e organização do cuidado nos serviços
More news about: MSD
Sep 10, 2026, 07:00 ET BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
where more effective treatments are desperately needed.In two orthotopic GBM xenograft models (SNB19, slower-growing; U87-MG, aggressive), oral GLIX1 (75 mg/kg QD to 1000 mg/kg BID) produced dose-dependent tumor growth inhibition and survival benefit at all tested doses, with greater benefit at higher
More news about: BioLineRx Ltd.; Hemispherian AS
Sep 09, 2026, 16:47 ET PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices
bronchitis."Building on those milestones, PMI U.S. is expanding its flagship ZYN dry pouch lineup to include 1.5 mg and 8 mg options, in addition to the current 3 mg and 6 mg strengths. Offering a range of nicotine strengths helps ensure legal-age nicotine consumers can choose an option that aligns
More news about: PMI US Corporate Services, Inc.
Sep 09, 2026, 10:10 ET Relaxing Shower Turns to Puppy Panic
pain control. While safe to use for humans, naproxen is very poisonous to dogs and cats, as it has a very narrow margin of safety. As little as one 220mg tablet can cause very serious symptoms, including death, in both dogs and cats.Wren took Phaedra to
More news about: Pet Poison Helpline
Sep 09, 2026, 09:00 ET RYZE Introduces Limited-Edition Pumpkin Spice Latte Mushroom Coffee, Exclusively at Target
features:A rich, creamy pumpkin spice latte flavorA warming blend of cinnamon, ginger, allspice, cloves, and nutmeg1,000mg of USA-grown organic SUPER6™ functional mushrooms100% vegan ingredientsWhether it's part of a morning commute, a work-from-home
More news about: RYZE
Sep 09, 2026, 08:17 ET Nanit CEO Anushka Salinas Welcomes Alexi Coffey From WHOOP and Geoff Wylde From ŌURA to Its Leadership Team, Signaling Next Phase of Growth
expansion into new areas of health, including longevity and women's health, introduced AI-powered personalized guidance, and launched WHOOP 5.0 and WHOOP MG. At Nanit, she will lead product and design as the company expands how technology can help parents understand their children.Geoff Wylde (dad of
More news about: Nanit
Sep 09, 2026, 08:00 ET MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
DA-1726," stated Hyung Heon Kim, President and Chief Executive Officer of MetaVia. "In our previously reported Phase 1 study, patients receiving the 48 mg dose of DA-1726 achieved a mean reduction in waist circumference of 9.8 cm after only eight weeks of treatment (Day 54). We believe the preferential
More news about: MetaVia Inc.
Sep 09, 2026, 08:00 ET STORM Names Kate Mackz as Newest Brand Ambassador
and empowers individuals to perform at their best—every day. Built at the intersection of fitness, lifestyle and community, each 12 oz. can contains 200mg of caffeine and is formulated to improve focus, help boost metabolism and promote fat burning in combination with exercise and a healthy diet. STORM
More news about: STORM
Sep 09, 2026, 07:00 ET Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
for oral dabogratinib were favorable across the 60 mg QD (n=22) and 50 mg QD (n=22) dose cohorts. Most treatment-emergent adverse events (TEAEs) were Grade 1 or 2, with Grade 3 TEAEs in 3 participants (14%) at 60 mg and 2 participants (9%) at 50 mg. Grade 3 treatment-related AEs occurred in 2 of 44 participants
More news about: Tyra Biosciences
Sep 08, 2026, 09:52 ET Nootropics Depot Launches SulfoMax, the World's Highest Sulforaphane Supplement
active. Within that window, the enzyme, supplied by 240mg of white mustard seed powder, the richest myrosinase source among the brassicas the company evaluated, hydrolyzes the glucoraphanin from 360mg of black kale extract standardized to 17%. A 12mg dose of vitamin C serves as a cofactor that pushes the
More news about: Nootropics Depot
Sep 08, 2026, 09:00 ET IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
population reflects exposure to intravenous IMDELLTRA®, as a single agent, at the recommended dosage of IMDELLTRA® 1 mg on Cycle 1 Day 1 followed by 10 mg on Days 8 and 15, and then every 2 weeks until disease progression or intolerable toxicity in 473 patients with small cell lung cancer
More news about: Amgen
Sep 08, 2026, 08:00 ET Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026
www.fda.gov/medwatch.CAPLYTA is available in 42 mg, 21 mg, and 10.5 mg capsules.Please see full
More news about: Johnson & Johnson
Sep 08, 2026, 06:45 ET New clinical evidence presented at PAINWeek 2026 demonstrates the powerful, long-lasting relief of TYLENOL® with Naproxen in post-surgical pain studies
combination.Study results support the recent FDA approval of the first and only over-the-counter (OTC) combination of acetaminophen (650 mg) and naproxen sodium (220 mg) in a single product, filling a longstanding need for a simple option that quickly delivers potent, long-lasting pain relief.
More news about: Kenvue Inc.
Sep 08, 2026, 06:10 ET Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity
delivery of oral peptides.In non-human primates (NHPs), 10 mg ASC36 oral tablet per animal dosed once daily for seven days achieved absolute oral bioavailability[1] of 8% and elimination half-life of 116 hours at steady state; 25 mg ASC36 oral tablet per animal dosed once daily for seven days
More news about: Ascletis Pharma Inc.